(Q42981859)

12 November 2017

Antibody response to E2/NS1 hepatitis C virus protein in patients with acute hepatitis C. (English)

1 reference

12 November 2017

1 reference

1 reference

Kobayashi M

1

1 reference

12 November 2017

Tanaka E

2

1 reference

12 November 2017

Matsumoto A

3

1 reference

12 November 2017

Ichijo T

4

1 reference

12 November 2017

Kiyosawa K

5

1 reference

12 November 2017

1 January 1997

1 reference

Journal of Gastroenterology and Hepatology

12 November 2017

1 reference

12 November 2017

12

1 reference

12 November 2017

73-76

1 reference

12 November 2017

1

1 reference

An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis

12 November 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00350.X

Diagnosis of hepatitis C virus (HCV) infection using an immunodominant chimeric polyprotein to capture circulating antibodies: reevaluation of the role of HCV in liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00350.X

Antibody response to core, envelope and nonstructural hepatitis C virus antigens: comparison of immunocompetent and immunosuppressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00350.X

A structurally flexible and antigenically variable N-terminal domain of the hepatitis C virus E2/NS1 protein: implication for an escape from antibody.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00350.X

Clinical significance of antibodies to nonstructural and core proteins of hepatitis C virus in posttransfusion hepatitis patients during long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00350.X

Viral and host factors that contribute to efficacy of interferon-alpha 2a therapy in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00350.X

A proposed system for the nomenclature of hepatitis C viral genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00350.X

Antibody to hepatitis C virus second envelope (HCV-E2) glycoprotein: a new marker of HCV infection closely associated with viremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00350.X

Vaccination of chimpanzees against infection by the hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00350.X

Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00350.X

Influence of different hepatitis C virus genotypes on the course of asymptomatic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00350.X

The natural course of chronic hepatitis C: a comparison between patients with genotypes 1 and 2 hepatitis C viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00350.X

10.1111/J.1440-1746.1997.TB00350.X

21 January 2018

Identifiers

DOI

1 reference

12 November 2017

1 reference